With the new INVOS™ regional oximetry strategic partner solution, adding noninvasive brain oxygenation and tissue perfusion patient monitoring to your portfolio is easy and efficient.
The new INVOS™ regional oximetry strategic partner solution is the first external fully-featured NIRS-based cerebral/somatic oximetry available for OEM integration.
Clinicians are increasingly adopting regional saturation monitoring for the early detection of cerebral hypoxia([FOOTNOTE=Vretzakis G, Georgopoulou S, Stamoulis K, et al. Cerebral oximetry in cardiac anesthesia. J Thorac Dis. 2014;6 Suppl 1:S60-69.],[ANCHOR=],[LINK=]) and to monitor changes in perfusion in neonates and infants. By integrating INVOS™ technology you can offer your customers the unique benefits of market-leading INVOS™ technology.
INVOS™ (IN VIVO OPTICAL SPECTROSCOPY) TECHNOLOGY FOR OEM MONITORING SOLUTIONS
Developed as a complete packaged OEM system, the INVOS™ Regional Oximetry Strategic Partner Solution includes:
The external cable design offers a simple technical integration without the mechanical space constraints of standard PCBA platform designs. And, the INVOS™ regional oximetry strategic partner solution provides the same full complement of features and functionality as the INVOS™ 5100c monitor, including:
Engineered for ease of integration, the INVOS™ regional oximetry strategic partner solution provides evaluation and development toolkits, best practice user interface guides, global OEM technical and clinical expertise, and dedicated OEM partner online and on site support. You also get the clinical education resources needed to train your clinicians and teams on the applications and benefits of adopting INVOS™ regional saturation monitoring. Computer-based training modules on haemodynamics and applied learning with clinical case studies provide education about monitoring during adult cardiac surgery.